Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Livestock Dewormers Market
The global livestock dewormers market size was valued at USD 7.9 billion in 2024 and is estimated to grow at a CAGR of 4.8% from 2025 to 2034. The growth of the market is primarily driven by the rising demand for animal protein and dairy products globally.
With the increasing population and urbanization, the demand for meat, milk, and other livestock-derived products is escalating, necessitating the maintenance of herd health to optimize production. For instance, according to the Food and Agriculture Organization (FAO), global meat production is expected to reach 374 million tonnes by 2030, a 13% increase from 2018-2020 levels. Parasite infestations significantly impact animal growth and productivity, making dewormers an essential component of livestock healthcare.
Additionally, favorable government initiatives promoting veterinary health, and the implementation of stringent food safety regulations further contribute to the increased adoption of dewormers. Furthermore, the growing awareness about the economic losses caused by parasitic infections and the rising emphasis on animal welfare among livestock owners are encouraging the regular use of dewormers. Emerging markets in Asia-Pacific, Latin America, and Africa are also contributing to market growth, driven by expanding livestock populations and increasing investments in veterinary healthcare infrastructure.
Livestock dewormers, also known as anthelmintics, are medications or chemical agents used to eliminate or control parasitic worms (helminths) in livestock such as cattle, sheep, goats, pigs, poultry, and other farm animals. These parasites may include roundworms, tapeworms, flukes, and other internal worms that can negatively impact the health, productivity, and overall well-being of livestock.
Report Attribute | Details |
---|---|
Base Year: | 2024 |
Livestock Dewormers Market Size in 2024: | USD 7.9 Billion |
Forecast Period: | 2025 to 2034 |
Forecast Period 2025 to 2034 CAGR: | 4.8% |
2034 Value Projection: | USD 12.4 Billion |
Historical Data for: | 2021 - 2023 |
No. of Pages: | 130 |
Tables, Charts & Figures: | 108 |
Segments covered: | Animal Type, Drug Class, Mode, Route of Administration, Distribution Channel, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|